Home » Stocks » RTIX

RTI Surgical Holdings, Inc. (RTIX)

Jul 23, 2020 - Stock symbol was changed to SRGA (reason: company name changed)
Stock Price: $3.14 USD 0.00 (0.00%)
Updated Jul 22, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap 234.25M
Revenue (ttm) 312.09M
Net Income (ttm) -220.15M
Shares Out 74.60M
EPS (ttm) -2.93
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 22, 2020
Last Price $3.14
Previous Close $3.14
Change ($) 0.00
Change (%) 0.00%
Day's Open 3.26
Day's Range 2.85 - 3.39
Day's Volume 354,602
52-Week Range 1.46 - 5.40

More Stats

Market Cap 234.25M
Enterprise Value 403.36M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 74.60M
Float 68.26M
EPS (basic) -3.02
EPS (diluted) -2.93
FCF / Share -0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.35M
Short Ratio 2.53
Short % of Float 1.97%
Beta 2.14
PE Ratio n/a
Forward PE 526.32
P/FCF Ratio n/a
PS Ratio 0.75
PB Ratio 15.41
Revenue 312.09M
Operating Income -192.31M
Net Income -220.15M
Free Cash Flow -3.29M
Net Cash -169.12M
Net Cash / Share -2.27
Gross Margin 55.87%
Operating Margin -61.62%
Profit Margin -70.60%
FCF Margin -1.05%
ROA -0.93%
ROE -113.98%
ROIC -60.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(69.75% upside)
Current: $3.14
Target: 5.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth9.99%0%1.58%-2.23%7.41%32.75%11.15%5.2%1.89%-
Gross Profit17114014313315013480.1185.2277.2176.00
Operating Income-182-4.31-4.75-15.2624.635.63-28.6612.2411.77-127
Net Income-212-3.126.91-13.8114.922.70-17.818.408.38-129
Shares Outstanding72.8263.5259.6858.2457.6156.7456.2655.8655.1554.73
Earnings Per Share-2.91-0.080.05-0.300.20-0.01-0.340.150.15-2.36
EPS Growth-------0%--
Operating Cash Flow-9.4617.255.7915.329.006.89-4.4520.8027.7729.39
Capital Expenditures-14.43-11.04-10.48-15.34-17.74-15.58-15.01-11.09-6.35-3.24
Free Cash Flow-23.886.21-4.70-0.01-8.74-8.68-19.479.7121.4226.15
Cash & Equivalents5.6110.9522.3813.8512.6115.7018.7249.7046.1828.21
Total Debt17449.0746.3483.3579.2475.8969.050.120.593.00
Net Cash / Debt-169-38.12-23.96-69.50-66.62-60.19-50.3349.5845.5925.22
Book Value34.56182182165181168168184172162
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name RTI Surgical Holdings, Inc.
Country United States
Employees 935
CEO Camille I. Farhat

Stock Information

Ticker Symbol RTIX
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: RTIX
IPO Date August 10, 2000


RTI Surgical Holdings, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.